News18» News»Business»Serum Institute to Seek Rs 100 Cr in Damages from Virus Vaccine Trial Participant Over 'Malicious' Claims of Side Effects
1-MIN READ

Serum Institute to Seek Rs 100 Cr in Damages from Virus Vaccine Trial Participant Over 'Malicious' Claims of Side Effects

A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker of vaccines, which is working on vaccines against the coronavirus disease (COVID-19) in Pune. (Image used for representation: Reuters)

A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker of vaccines, which is working on vaccines against the coronavirus disease (COVID-19) in Pune. (Image used for representation: Reuters)

A 40-year-old man who took part in the 'Covidshield' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and has sought Rs 5 crore compensation in a legal notice to Serum Institute and others, besides seeking a halt to the trial.

Vaccine major Serum Institute of India on Sunday rejected charges that a COVID-19 vaccine candidate has serious side effects, and threatened to seek heavy damages for "malicious" allegations. A 40-year-old man who took part in the 'Covidshield' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions and has sought Rs 5 crore compensation in a legal notice to Serum Institute and others, besides seeking a halt to the trial.

"The allegations in the notice are malicious and misconceived. While the Serum Institute of India is sympathetic with the volunteer's medical condition, there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer," Serum Institute of India said in a statement. The volunteer is falsely laying the blame for his medical problems on the COVID vaccine trial,it added.

"It is evident that the intention behind the spreading of such malicious information is an oblique pecuniary motive. The Serum Institute of India, will seek damages in excess of 100 crore for the same and will defend such malicious claims," Serum Institute said. Pune-based Serum Institute of India (SII) has collaborated with Oxford University and pharmaceutial company Astra Zeneca for making the COVID-19 vaccine, 'Covidshield', and is conducting trials in India.

first published:November 29, 2020, 20:38 IST